The Wharton Moneyball Post Game Podcast

Share

Wharton Moneyball: MLB Hall of Fame, Sports Tech & Analytics, and The 2019 Super Bowl

Ep. 134

Show from 1/23/19


This week on Wharton Moneyball, we have our whole team, Cade, Shane, Adi, and Eric talking about the MLB Hall of Fame. What will be the outcome for Barry Bonds and Roger Clemens? Then they switch to the NFL to talk pass vs runs stats, scoring, and play calling logic with the co-founder of Edj Analytics. Plus they get into wearable tech and innovation in the space of motion tracking data. All that and more



Guests:

Frank Frigo - Co-Founder of Edj Analytics. Edj Analytics. He has consulted with several NFL and NCAA Division 1 football programs and his work in sports analytics has been prominently featured in Esquire, Foxsports, ESPN, The New York Times and Showtime’s “Inside the NFL"

Follow him on Twitter @edjanalytics


Steve Gera - CEO at Gains Group, where he works to leverage data for long term value. He is also the former Head of Innovation at the Cleveland Browns and was brought in by the Chargers to “do Moneyball” in the mid-2000s. 

Check out his website: http://www.stevegera.com/


More Episodes

7/22/2020

7/22/2020: COVID-19, Sports, David Fajgenbaum

David Fajgenbaum, MD, MBA, MSc is a groundbreaking physician-scientist, disease hunter, and bestselling author of the acclaimed memoir, Chasing My Cure: A Doctor's Race to Turn Hope Into Action. Fajgenbaum went from being a beast-like college Quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, he spearheaded an innovative approach to research and discovered a possible treatment that has put him into an extended remission. Now, he is spreading this approach to advance cures for other diseases and sharing lessons he learned about living from nearly dying through Chasing My Cure.One of the youngest individuals ever appointed to the faculty at Penn Medicine and the top 1 percent youngest grant awardees of a leading NIH grant, Dr. Fajgenbaum is co-founder and executive director of the Castleman Disease Collaborative Network (CDCN) and Associate Director, Patient Impact, for the Penn Orphan Disease Center. He has been recognized on the Forbes 30 Under 30 list, as a top healthcare leader by Becker's Hospital Review, the Global Genes RARE Champion of Hope: Science awardee, and one of three recipients--including Vice President Joe Biden--of a 2016 Atlas Award from the World Affairs Council of Philadelphia. Before co-founding the CDCN, Dr. Fajgenbaum co-founded and led the Actively Moving Forward Support Network, a non-profit organization dedicated to supporting grieving college students. Dr. Fajgenbaum has been profiled in a cover story by The New York Times as well as by Good Morning America, CNN, and the Today Show, among others.Dr. Fajgenbaum earned a BS from Georgetown University magna cum laude with honors and distinction, MSc from the University of Oxford, MD from the University of Pennsylvania Medical School, and MBA from The Wharton School. He is a former Division I college quarterback, state-champion weight lifter, and co-founder of a national grief support network.